Evidence map›Paper›PMID 32316562›Full record

ReviewInternational journal of molecular sciences2020

Clinical Spectrum of

Kelsey Paulhus, Lauren Ammerman, Edward Glasscock

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches.Tremor and other hyperkinetic movements (New York, N.Y.) · 2023
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Properties of Heterochannels Kv(1.1-1.2)International journal of molecular sciences · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Genetic Background of Epilepsy and Antiepileptic Treatments.International journal of molecular sciences · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kelsey PaulhusDepartment of Biological Sciences, Southern Methodist University, Dallas, TX 75275, USA.
Lauren AmmermanDepartment of Biological Sciences, Southern Methodist University, Dallas, TX 75275, USA.ORCID 0000-0001-9164-0932
Edward GlasscockDepartment of Biological Sciences, Southern Methodist University, Dallas, TX 75275, USA.ORCID 0000-0001-8702-2349

Funding

Respiratory mechanisms of epilepsy with high risk of SUDEPR01NS100954 · NINDS · SOUTHERN METHODIST UNIVERSITY · PI GLASSCOCK, ALBERT E · 2017 to 2021
$1.6M
Neurocardiac mechanisms of epilepsy with high risk of SUDEPR01NS099188 · NINDS · SOUTHERN METHODIST UNIVERSITY · PI GLASSCOCK, ALBERT E · 2017 to 2020
$1.3M
NIH HHS R01NS099188NIH HHS R01NS100954NINDS NIH HHS R01 NS099188NINDS NIH HHS R01 NS100954
6 · The paper itself

Abstract

Mutations in the

Indexed as

MutationAnimalsAtaxiaComorbidityEpilepsyGenetic Association StudiesHumansKv1.1 Potassium ChannelProtein DomainsKCNA1 protein, humanKv1.1 Potassium Channelepilepsyepisodic ataxiaKCNA1Kv1.1

Identifiers

PMID32316562
PMCPMC7215408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.